Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

FDA puts Cardinal Health kit correction in top risk tier over BD Alaris sets

Cardinal Health's relabelling of Presource convenience kits that may hold recalled BD Alaris infusion sets now carries the FDA's highest hazard rating, extending a recall's reach into the kit supply chain.

17 Nov 2026 · FDA MedWatch · Regulator

Cardinal Health's correction of certain Presource convenience kits has been given the FDA's highest hazard rating, Class I. The agency's update is dated 16 November 2026 and was published the next day. It follows an Early Alert of 20 October, and the FDA says the products covered and the actions recommended are unchanged.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: FDA MedWatch ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →